...
首页> 外文期刊>Investigative radiology >Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
【24h】

Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.

机译:兔对比增强磁共振血管造影:与g状葡甲胺相比,evaluation基药物p846和铁基血池药物p904的评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: : To evaluate the performance of a gadolinium-based contrast compound (P846) as well as an ultra-small particle of iron oxide agent (P904) in contrast-enhanced magnetic resonance angiography (MRA) in rabbits and to compare those agents with gadoterate meglumine (Gd-DOTA) for first pass and steady state imaging. MATERIALS AND METHODS: : A total of 6 rabbits underwent contrast-enhanced MRA of the aorta and its branches at 3 different time points. All examinations were performed on a 1.5T MR (Siemens HealthCare, Magnetom Espree), and the contrast agents were applied in random order. Image data were acquired using a time-resolved MRA sequence (time-resolved angiography with stochastic trajectories) during the first pass to assess the bolus phase and a high-resolution MRA sequence followed by repetitive measurements over the next 10 minutes for all 3 agents to evaluate the postbolus phase. Two radiologists reviewed the images in consensus blinded to the contrast agent used. Signal-to-noise ratio and contrast-to-noise ratio for three-dimensional high-resolution MRA were calculated for each time point and agent. Image quality was consensually evaluated on a 4-point Likert scale. A Wilcoxon-Mann-Whitney U test was used for comparison with P < 0.05 as level of statistical significance. RESULTS: : All agents led to diagnostic MR angiograms in all 6 rabbits. The time-resolved angiography with stochastic trajectories datasets provided detailed information about the bolus phase for all the 3 agents. During the first pass, P904 and P846 proved to be superior to Gd-DOTA with the highest peak enhancement for P846. In the postbolus phase up to 10 minutes postcontrast injection, P904 proved to be superior to the other agents. All the agents led to excellent image quality, with no statistical difference to a maximum of 3 minutes postinjection, whereas thereafter images with Gd-DOTA and P846 were assessed as nondiagnostic. CONCLUSIONS: : P846 and P904 proved to be superior to Gd-DOTA for time-resolved MRA. The ultra-small particle of iron oxide compound P904 showed continuous high signal over 10 minutes and seems to be best suited for first pass and steady-state imaging.
机译:目的:评估evaluate增强造影剂(P846)和超小氧化铁剂(P904)在兔造影剂磁共振血管造影(MRA)中的性能,并将这些剂与ado状葡甲胺(Gd-DOTA)用于首过和稳态成像。材料与方法:共有6只兔子在3个不同的时间点进行了主动脉及其分支的对比增强MRA。所有检查均在1.5T MR(Siemens HealthCare,Magnetom Espree)上进行,并且造影剂以随机顺序使用。在第一遍中使用时间分辨MRA序列(时间分辨血管造影术具有随机轨迹)获取图像数据,以评估推注阶段和高分辨率MRA序列,然后在接下来的10分钟内对所有3种药物重复测量评估推注后阶段。两名放射科医生一致同意对所使用的造影剂不了解的图像进行了检查。针对每个时间点和每个代理,计算了三维高分辨率MRA的信噪比和对比度噪声比。同意以4点李克特量表对图像质量进行评估。使用Wilcoxon-Mann-Whitney U检验比较统计学显着性水平,P <0.05。结果::所有试剂均导致了所有6只兔的诊断性MR血管造影。具有随机轨迹数据集的时间分辨血管造影提供了有关所有3种药物的推注阶段的详细信息。在第一遍测试中,P904和P846被证明优于Gd-DOTA,其P846的峰值增强最高。在推注后直至造影剂注射后10分钟的阶段,P904被证明优于其他药物。所有试剂均导致出色的图像质量,注射后最多3分钟无统计学差异,而此后将具有Gd-DOTA和P846的图像评估为非诊断性图像。结论:在时间分辨的MRA中,P846和P904被证明优于Gd-DOTA。氧化铁化合物P904的超小颗粒在10分钟内显示出连续的高信号,似乎最适合首次通过和稳态成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号